Dow Down 0.32% Nasdaq Down 0.62%

Gilead Sciences Inc. (GILD)

-NasdaqGS
88.21 Down 8.79(9.06%) Apr 29, 4:00PM EDT
|After Hours : 88.37 Up 0.16 (0.18%) Apr 29, 7:57PM EDT
Prev Close:97.00
Open:91.19
Bid:88.25 x 100
Ask:88.38 x 200
1y Target Est:111.48
Beta:1.25203
Earnings Date:Jul 26 - Aug 1 (Est.)
Day's Range:87.80 - 92.53
52wk Range:81.89 - 123.37
Volume:33,629,186
Avg Vol (3m):12,641,200
Market Cap:119.49B
P/E (ttm):7.41
EPS (ttm):11.91
Div & Yield:1.72 (1.70%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Related Video

Comparison

Symbol% ChgMkt Cap
GILDDown 9.06%119.49B
GSKDown 1.04%103.84B
PFEDown 0.61%202.54B

Key Statistics

Forward P/E (1 yr):7.13
P/S (ttm):4.06
Ex-Dividend Date:14-Mar-16

Analysts

Annual EPS Est (Dec-16) :12.18
Quarterly EPS Est (Jun-16) :3.00
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):5.79

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Gilead Sciences, Inc., a research-based biopharmaceutical company, discovers, develops, and commercializes medicines in areas of unmet medical needs in North America, South America, Europe, and the Asia-Pacific. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback